http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58222024-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_420221507eb0ce109b0a2c8b4c2cf6b7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
filingDate 1982-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0b8633b3fe7749ce9bdf84176ce6d0
publicationDate 1983-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S58222024-A
titleOfInvention Antitumor agent
abstract PURPOSE: An antitumor agent, containing a metl mixture of cod-liver oil containing a specific amount of iodine with borneol, effective for preventing or suppressing the multiplication of various tumors, and administrable continuously without side effects. n CONSTITUTION: An antitumor agent containing a melt mixture of cod-liver oil containing 6.5W7.5wt% combined iodine with borneol as an active constiuent. The antitumor agent is usually administered orally, and the dialy dose thereof is 0.5W30g, preferably 1W20g, expressed in terms of the active constituent (the melt mixture) for adults. The above-mentioned melt mixture is obtained by melting 70W90pts.wt. cod-liver oil under heating at 180W230°C, adding 6W8pts.wt. iodine and 7W9pts.wt. borneol (melting point: 210W213°C; purity: ≥97%) in order, stirring the resultant mixture under heating to form a homogeneous dark-brown viscous oily liquid, and cooling the resultant oily liquid to room temperature. n COPYRIGHT: (C)1983,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6060007-U
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0316088-Y2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021198938-A1
priorityDate 1982-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6552009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID230920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439291

Total number of triples: 28.